A single-center analysis of visual outcomes and associated factors after intravenous methylprednisolone treatment for dysthyroid optic neuropathy

Abstract Background Dysthyroid optic neuropathy (DON) is a serious threatening vision loss in Graves’ ophthalmopathy (GO). Although the European Group on Graves’ Ophthalmopathy (EUGOGO) recommend intravenous methylprednisolone therapy for first line treatment, some characteristics predicting the res...

Full description

Bibliographic Details

Published in:	BMC Ophthalmology
Main Authors:	Parinee Kemchoknatee, Duanghathai Tangon, Thansit Srisombut
Format:	Article
Language:	English
Published:	BMC 2023-01-01
Subjects:	Dysthyroid optic neuropathy Graves orbitopathy Thyroid eye disease Intravenous glucocorticoids. Intravenous methylprednisolone
Online Access:	https://doi.org/10.1186/s12886-023-02789-5